Stay updated with breaking news from Nasdaq Repl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emerald Mutual Fund Advisers Trust lessened its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 16.8% during the 1st quarter, Holdings Channel reports. The firm owned 803,448 shares of the company’s stock after selling 162,490 shares during the quarter. Emerald Mutual Fund Advisers Trust’s holdings in Replimune Group were worth $14,189,000 at the […]
Replimune Group (NASDAQ:REPL – Get Rating) had its price target raised by HC Wainwright from $50.00 to $51.00 in a research report released on Monday, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at ($0.88) EPS, Q4 […]
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Wedbush cut their FY2024 earnings per share estimates for shares of Replimune Group in a research note issued to investors on Monday, May 22nd. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($3.95) per share for the year, down from their previous […]
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has received an average rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued ratings on the stock in the […]
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Investment analysts at Wedbush issued their Q1 2024 earnings estimates for shares of Replimune Group in a research report issued on Monday, May 22nd. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.87) per share for the quarter. The consensus estimate for Replimune […]